Triple Negative Breast Cancer (TNBC): Adding ipatasertib to paclitaxel does not improve survivalAugust 31, 2021Breast Cancer
HER2-positive breast cancer: Add-on trastuzumab lowers recurrence and mortalityAugust 31, 2021Breast Cancer
Breast cancer: 10-year treatment extension with aromatase inhibitors yields no benefitAugust 31, 2021Breast Cancer
Oncology PracticePandemic-related drops in breast cancer screening hit hardest among medically underservedAugust 30, 2021Breast CancerPreventive Care
Oncology PracticeGender-affirming mastectomy and breast cancer screening in transmasculine patientsAugust 27, 2021Breast Cancer
Oncology PracticePolygenic breast cancer risk scores strive to overcome racial biasAugust 24, 2021Breast CancerMetastatic Breast CancerDiversity in Medicine
Oncology PracticeInternal mammary lymph node radiation safe over the long termAugust 11, 2021Breast Cancer
Oncology PracticeInternal mammary lymph node radiation safe over the long termAugust 9, 2021Breast Cancer
Oncology PracticeHow many years of aromatase inhibitor therapy in breast cancer?August 4, 2021Breast Cancer
Oncology PracticeOne in three cancer articles on social media has wrong infoAugust 4, 2021Lung CancerBreast CancerGastrointestinal CancerCNS/Brain CancerHead & Neck/Thyroid CancersGynecologic CancerGenitourinary Cancer
Oncology PracticeFDA approves neoadjuvant pembro for triple-negative breast cancerAugust 4, 2021Breast Cancer
Breast reconstruction: Chemotherapy does not increase complications and patient-reported outcomesJuly 29, 2021Breast Cancer
